Streetbeat News

Analyst Ratings

QSR

Barclays analyst Jeffrey Bernstein maintains an Overweight rating on Restaurant Brands Intl (NYSE:QSR) and raises the price target from $84 to $86.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 4:14 pm

NEO

Benchmark analyst Bruce Jackson maintains a Buy rating on NeoGenomics (NASDAQ:NEO) but lowers the price target from $20 to $18.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 09, 2023 | 4:14 pm

RIVN

Rivian Automotive Inc (NASDAQ:RIVN) reported Q2 earnings with revenue of $1.12 billion, beating the consensus estimate of $978.9 million. The company's operating expenses decreased from $1 billion YoY to $873 million. Rivian produced 13,992 vehicles in Q2, with 12,640 successful deliveries. Analysts from BofA, Mizuho, and Cantor Fitzgerald reiterated their ratings on the stock, with BofA and Mizuho raising their price targets.

Portfolio Pulse from AJ Fabino

August 09, 2023 | 4:13 pm

RIVN

Deutsche Bank analyst Emmanuel Rosner has maintained a 'Buy' rating on Rivian Automotive (NASDAQ:RIVN) and raised the price target from $26 to $29.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 09, 2023 | 4:12 pm

EGRX

Piper Sandler analyst David Amsellem has downgraded Eagle Pharmaceuticals (NASDAQ:EGRX) from Neutral to Underweight and lowered the price target from $26 to $17.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 4:12 pm

LZ

Barclays analyst Mario Lu maintains an Overweight rating on LegalZoom.com (NASDAQ:LZ) and raises the price target from $12 to $17.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 4:11 pm

JAMF

Barclays analyst Raimo Lenschow maintains an Overweight rating on Jamf Holding (NASDAQ:JAMF) but lowers the price target from $25 to $22.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 4:10 pm

JRVR

Barclays analyst Tracy Benguigui has maintained an Equal-Weight rating on James River Gr Hldgs (NASDAQ:JRVR) and lowered the price target from $18 to $17.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 4:09 pm

LLY

Barclays analyst Carter Gould maintains an Overweight rating on Eli Lilly (NYSE:LLY) and raises the price target from $500 to $590.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 4:08 pm

LCII

CJS Securities analyst Daniel Moore has downgraded LCI Indus (NYSE:LCII) from Market Outperform to Market Perform.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 4:07 pm